NAPHARM LIMITED - Accounts

NAPHARM LIMITED
Statement of Financial Position
As at 31 March 2025

	2025		2024
	£	£	£	£
Fixed assets		973		973
Current assets	30,885		30,635
Creditors: amount falling due within one year	(10,398)		(7,139)
Net current assets		20,487		23,496
Total assets less current liabilities		21,460		24,469
Net assets		21,460		24,469


Capital and reserves		21,460		24,469

NOTES TO THE ACCOUNTS

General Information

NAPHARM LIMITED is a private company, limited by shares, registered in England and Wales, registration number 09532216, registration address 15 Harcourt Road, SUNDERLAND , SR2 9JR.

The presentation currency is £ sterling.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.

The financial statements are prepared in sterling which is the functional currency of the company.

Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

Tangible fixed assets

Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:

Plant and Machinery

0% Reducing Balance

Tangible fixed assets

Cost or valuation	Plant and Machinery	Total
	£	£
At 01 April 2024	2,149	2,149
Additions	-	-
Disposals	-	-
At 31 March 2025	2,149	2,149
Depreciation
At 01 April 2024	963	963
Charge for year	213	213
On disposals	-	-
At 31 March 2025	1,176	1,176
Net book values
Closing balance as at 31 March 2025	973	973
Opening balance as at 01 April 2024	973	973

Staff Costs

	2025	2024

Average number of employees during the year	Number	Number
Administration	0	2
	0	2

4.	Average number of employees Average number of employees during the year was 0 (2024 : 2).

For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.

The financial statements were approved by the director on 13 October 2025 and were signed by:

--------------------------------
Nana Bosa Obiri-Yeboah
Director

Registered Number: 09532216
England and Wales
NAPHARM LIMITED

Micro Entity

Period of accounts Start date: 01 April 2024 End date: 31 March 2025